METHODS	Norfloxacin 400 mg/day with probiotics capsules ( Enterococcus faecalis JPC 30 million , Clostridium butyricum 2 million , Bacillus mesentericus JPC 1 million , Bacillus coagulans 50 million spores ) at a dose of two capsules three times daily ( group 1 ) or norfloxacin with a placebo ( group 2 ) was given and the occurrence of SBP within a period of 6 months ( primary endpoint ) or side-effects of therapy and mortality ( secondary endpoints ) were recorded .\